Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes.
about
Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluationAntibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery.A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects.Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study.Ocular Pharmacokinetics.
P2860
Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@en
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@nl
type
label
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@en
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@nl
prefLabel
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@en
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@nl
P2093
P2860
P356
P1476
Ocular pharmacokinetics of bim ...... tion in pigmented rabbit eyes.
@en
P2093
Afshin Shafiee
Kamran Hosseini
Lyle M Bowman
P2860
P304
P356
10.2147/OPTH.S48766
P407
P577
2013-07-31T00:00:00Z